Biotech

Biotechnology & Sustainability News

Biotechnology & Sustainability Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 07.04.2022.

#ClinicalResearchNews
#PharmiwebNews
#PharmaNews
#MedicalNews
#BiotechNews
#LifeSciencesNews
#HealthcareNews
#news
#pharma

Sustainability

@gmopundit shared
On Apr 6, 2022
RT @Iuisventura: This is the most recent piece I've done for @GeneticLiteracy about how the consequences derived from the ban on glyphosate are already affecting agriculture in Mexico, and jeopardizing the farmer's and environment's well-being. https://t.co/BfMTCYqjWv
Open
Mexico’s plan to ban glyphosate by 2024 is already backfiring against farmers, consumers and the environment

Mexico’s plan to ban glyphosate by 2024 is already backfiring against farmers, consumers and the environment

The Mexican government is still on track to ban completely by 2024 the use of glyphosate which is paired with transgenic corn. GMO corn is already banned

@prometheusgreen shared
On Apr 3, 2022
Viewpoint: Gene editing crops is the very definition of ‘green technology’ https://t.co/OzK6IgNpAM via @GeneticLiteracy
Open
Viewpoint: Gene editing crops is the very definition of ‘green technology’

Viewpoint: Gene editing crops is the very definition of ‘green technology’

One thing we have learnt from the GMO debate is that if you simply add layers of regulatory checks and controls, you just end up increasing people’s

@pharminews shared
On Apr 4, 2022
BRAIN Biotech AG: Successful Genome Editing Activity in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC) https://t.co/aU47BzrcLp #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/G9X9Roza4Y
Open
BRAIN Biotech AG: Successful Genome Editing Activity in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC)

BRAIN Biotech AG: Successful Genome Editing Activity in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC)

BRAIN Biotech AG / Key word(s): MiscellaneousBRAIN Biotech AG: Successful Genome Editing Activity in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC) 04-Apr-2022 ...

@pharminews shared
On Apr 7, 2022
Dupixent® (dupilumab) approved by European Commission for children aged 6 to 11 years with severe asthma with type 2 inflammation https://t.co/yCEUkLfCIW #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/xmcnEtJnyt
Open
Dupixent® (dupilumab) approved by European Commission for children aged 6 to 11 years with severe asthma with type 2 inflammation

Dupixent® (dupilumab) approved by European Commission for children aged 6 to 11 years with severe asthma with type 2 inflammation

 Dupixent® (dupilumab) approved by European Commission for children aged 6 to 11 years with severe asthma with type 2 inflammation Dupixent is the only biologic indicated in ...

@pharminews shared
On Apr 5, 2022
Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies https://t.co/bqKkUdzFg3 #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/9C8gK9xKfi
Open
Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies

Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies

BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Optimal Industrial Automation and Technologies, a leader in pharma and ...

@JonEntine shared
On Apr 5, 2022
Modified: Destigmatizing GMOs one bite at a time https://t.co/EXE9GkGYUq via @GeneticLiteracy
Open
Modified: Destigmatizing GMOs one bite at a time

Modified: Destigmatizing GMOs one bite at a time

“GMOs have been unfairly stigmatized, haven’t they?”Thus spoke a man in his 30s, a sympathetic expression on his face, as he took a bite of genetically

@pharminews shared
On Apr 5, 2022
EZEN Partners With ComplianceQuest to Support Clients' Digital Transformation https://t.co/I9RHfXcajt #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/CMNdFCNNpu
Open
EZEN Partners With ComplianceQuest to Support Clients' Digital Transformation

EZEN Partners With ComplianceQuest to Support Clients' Digital Transformation

TAMPA, Fla. - April 5, 2022 - (Newswire.com) EZEN, a provider of digital transformation services to the Life Sciences and Healthcare Industry, today ...

@pharminews shared
On Apr 6, 2022
Takeda and the New York Academy of Sciences Announce 2022 Innovators in Science Award Winners https://t.co/7dOlsCYa7j #pharma #news
Open
Takeda and the New York Academy of Sciences Announce 2022 Innovators in Science Award Winners

Takeda and the New York Academy of Sciences Announce 2022 Innovators in Science Award Winners

Takeda (TSE:4502/NYSE:TAK) and the New York Academy of Sciences today announced the winners of the fourth Innovators in Science Award for their excellence in, and commitment to, innovative ...

Read more: Sustainability
weekly 07.04.2022
View archives
Back to home

Subscribe to Biotech - Biotechnology & Sustainability.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Biotechnology & Sustainability.
Privacy Policy

Sign up for the weekly Biotech - Biotechnology & Sustainability newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Biotechnology & Sustainability weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy